The field of biomedical research is shifting toward precision medicine through targeted approaches. The advancement of this research type requires better testing platforms that deliver improved accuracy and robustness and high-throughput capabilities. The Pharmaceutical and Diagnostic Testing Platforms from Creative Diagnostics operate as a proprietary analytical service suite which supports therapeutic product development and complex immune-mediated disease diagnosis. Our company provides pharmaceutical R&D and clinical diagnostics with targeted actionable insights through our advanced immunoassay technologies and methodologies and biomarker panels and disease-specific profiling kits.
Our platforms support immunogenicity testing and allergic sensitization or autoimmune response detection while maintaining industry-leading sensitivity and specificity and clinical relevance standards.
Our testing platforms encompass a wide array of immunological and serological assays, including:
The service modules operate with optimized protocols to generate reproducible data through validated methods which include standard or customized test panels and GLP/GMP-compliant reporting and expert data interpretation.
To provide focused solutions across immune-related conditions and pharmacological applications, our service portfolio is organized into the following three key platforms:
The worldwide increase of allergic diseases requires exact allergen-specific antibody testing for both diagnostic purposes and monitoring and immunotherapy evaluation. Our allergen testing platform provides precise detection of IgE- and IgG-mediated hypersensitivity reactions for multiple environmental and food allergens.
Sub-services include:
The measurement of IgE antibodies against particular allergens serves both clinical purposes of allergy diagnosis and risk assessment.
The detection of IgG/IgG4 antibodies helps identify delayed or non-IgE-mediated hypersensitivities which are commonly used in food intolerance assessments.
Targeted panels for inhalant allergens (e.g., pollen, mold, dust mites), occupational allergens, and venom allergens.
Systemic autoimmune diseases present with intricate immunopathological features together with diverse antibody patterns. Our platform enables high-throughput detection of disease-specific autoantibodies and cytokine markers which helps with diagnosis and classification and disease monitoring.
Target diseases include:
Each service combines serological profiling with optional add-ons such as ANA pattern classification, complement analysis, or inflammation panels.
The immune system attacks particular tissues in organ-specific autoimmune diseases. Our platform provides exact detection of autoantibodies and immune markers that target specific tissues which helps doctors make differential diagnoses and develop personalized treatment plans.
Test offerings cover:
Our Pharmaceutical and Diagnostic Testing Platforms are designed to support clinical diagnostics as well as to accelerate therapeutic development and safety assessment in pharmaceutical pipelines. From patient stratification and target validation to monitoring drug-induced autoimmunity or hypersensitivity, Creative Diagnostics delivers reliable, clinically relevant data to support every stage of translational research.
Contact us today to learn how our integrated platforms can support your pharmaceutical or diagnostic goals.
